cell-free DNA
The company had previously planned to develop IVD kits for the US market but is now aiming to launch a lab-developed test in the second half of 2022.
A new study has explored patterns in these molecules in pregnant women, showing potential for detection of fetal monogenic diseases and pregnancy complications.
Cell-Free DNA Can Help Predict Pathological Complete Response, Gauge Minimal Residual Disease
A suite of new studies examined how liquid biopsies could personalize treatment strategies in a range of cancer types.
Delfi Diagnostics Tags Lung Cancer as First Target for Fragmentation-Based Liquid Biopsy Tech
Premium
Based on promising early results, the company is now conducting a larger case-control study to lock in a classifier for prospective validation in an intended-use population.
The move opens the first non-oncology application for Oncocyte, which acquired the relevant cell-free DNA technology in its merger with Chronix this April.